Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E Adjustments
Ratios

Acro Biomedical (ACBM) Receivables - Net (2021 - 2023)

Acro Biomedical (ACBM) has 3 years of Receivables - Net data on record, last reported at $498500.0 in Q2 2023.

  • For Q2 2023, Receivables - Net rose 67.0% year-over-year to $498500.0; the TTM value through Jun 2023 reached $498500.0, up 67.0%, while the annual FY2022 figure was $638500.0, 6.77% up from the prior year.
  • Receivables - Net reached $498500.0 in Q2 2023 per ACBM's latest filing, down from $608500.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $638500.0 in Q4 2022 and bottomed at $278500.0 in Q3 2022.
  • Average Receivables - Net over 3 years is $459857.1, with a median of $498500.0 recorded in 2023.
  • Peak YoY movement for Receivables - Net: rose 6.77% in 2022, then surged 103.85% in 2023.
  • A 3-year view of Receivables - Net shows it stood at $598000.0 in 2021, then grew by 6.77% to $638500.0 in 2022, then decreased by 21.93% to $498500.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $498500.0 in Q2 2023, $608500.0 in Q1 2023, and $638500.0 in Q4 2022.